PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Ichthammol→

Ichthammol PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
8029-68-3
Molecular formula
Not available
Molecular weight
76.055 g/mol
Drug class
Sulfonated shale-oil derivativetopical anti-inflammatory and antiseptic ingredient
Mechanism of action
A complex sulfonated shale-oil preparation with reported local anti-inflammatory, antimicrobial and antipruritic effects. Proposed anti-inflammatory actions include inhibition of lipoxygenase and cyclooxygenase pathways; the composition is a mixture rather than a single molecular drug.
Indications / reported uses
  • Topical use in selected inflammatory skin preparations and drawing-salve products; specific indications depend on the registered formulation. Some US OTC ichthammol labels are marketed as unapproved homeopathic products and should not be treated as evidence of established efficacy.

Sources: https://www.ichthyol.de/en/raw-materials-for-corporate-customers/ichthammol/ · https://www.ndf.gov.sg/about-drugs/active-ingredient/m00462/ · https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bdbeeb95-5c46-9a24-e053-2a95a90aa397

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Ichthammol PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Ichthammol Permitted Daily Exposure (PDE) report (the Ichthammol PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Ichthammol Occupational Exposure Limit (OEL) report (the Ichthammol OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.